Biguanides (metformin and metformin) increase the AMP/ATP ratio mainly by inhibiting mitochondrial respiratory chain complex I, thus activating AMPK, further inducing catabolism process, increasing ATP level, reducing protein and lipid synthesis, and ultimately inhibiting tumor growth [38, 39]. The gene discussed is NDUFV1; the disease is neoplasm.